Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Sherman

Showing results (431-440 of 442) with videos related to

Pageof 45
Sort By:
Neurosurgery|December 20, 2007
Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety resultsMichael A Vogelbaum, John H Sampson, Sandeep Kunwar, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2000
Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. The Azithromycin Intravenous Clinical Trials GroupJ Plouffe, D B Schwartz, A Kolokathis, et al.
Neurosurgical Focus|May 20, 2006
Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studiesSandeep Kunwar, Susan M Chang, Michael D Prados, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2007
Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study GroupSandeep Kunwar, Michael D Prados, Susan M Chang, et al.
Annals of Clinical and Translational Neurology|March 27, 2019
Randomized, double-blind, placebo-controlled study of interferon-<i>γ</i> 1b in Friedreich AtaxiaDavid R Lynch, Lauren Hauser, Ashley McCormick, et al.
Journal of Medicinal Chemistry|January 25, 2002
Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteresDavid E Uehling, Kelly H Donaldson, David N Deaton, et al.
Gene Therapy|December 10, 2015
Safety and efficacy of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with critical limb ischemiaM R Kibbe, A T Hirsch, F O Mendelsohn, et al.
Gene Therapy|April 8, 2016
Safety and efficacy of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with critical limb ischemiaM R Kibbe, A T Hirsch, F O Mendelsohn, et al.
Journal of Medicinal Chemistry|April 28, 2006
Biarylaniline phenethanolamines as potent and selective beta3 adrenergic receptor agonistsDavid E Uehling, Barry G Shearer, Kelly H Donaldson, et al.
The New England Journal of Medicine|January 24, 2020
Teprotumumab for the Treatment of Active Thyroid Eye DiseaseRaymond S Douglas, George J Kahaly, Amy Patel, et al.
Pageof 45

Showing results (431-440 of 442) with videos related to

Sort By:
Pageof 45
Neurosurgery|December 20, 2007
Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety resultsMichael A Vogelbaum, John H Sampson, Sandeep Kunwar, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2000
Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. The Azithromycin Intravenous Clinical Trials GroupJ Plouffe, D B Schwartz, A Kolokathis, et al.
Neurosurgical Focus|May 20, 2006
Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studiesSandeep Kunwar, Susan M Chang, Michael D Prados, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2007
Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study GroupSandeep Kunwar, Michael D Prados, Susan M Chang, et al.
Annals of Clinical and Translational Neurology|March 27, 2019
Randomized, double-blind, placebo-controlled study of interferon-<i>γ</i> 1b in Friedreich AtaxiaDavid R Lynch, Lauren Hauser, Ashley McCormick, et al.
Journal of Medicinal Chemistry|January 25, 2002
Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteresDavid E Uehling, Kelly H Donaldson, David N Deaton, et al.
Gene Therapy|December 10, 2015
Safety and efficacy of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with critical limb ischemiaM R Kibbe, A T Hirsch, F O Mendelsohn, et al.
Gene Therapy|April 8, 2016
Safety and efficacy of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with critical limb ischemiaM R Kibbe, A T Hirsch, F O Mendelsohn, et al.
Journal of Medicinal Chemistry|April 28, 2006
Biarylaniline phenethanolamines as potent and selective beta3 adrenergic receptor agonistsDavid E Uehling, Barry G Shearer, Kelly H Donaldson, et al.
The New England Journal of Medicine|January 24, 2020
Teprotumumab for the Treatment of Active Thyroid Eye DiseaseRaymond S Douglas, George J Kahaly, Amy Patel, et al.
Pageof 45